Citric Complete Liquid Citric Acid Concentrate REF: LC+200-D,LC+201, LC+225(45X)
Nipro Renal Soultions USA, Corporation · Hemodialysis concentrates contain high endotoxin levels
Open FDA's page for this record- Cfres ID
- 221957
- Product res number
- Z-3136-2026
- Event date initiated
- 2026-08-05
- Event date posted
- 2026-09-10
- Recall status
- Open, Classified
- Res event number
- 99573
- Product code
- KPO
- Product description
- Citric Complete Liquid Citric Acid Concentrate REF: LC+200-D,LC+201, LC+225(45X)
- Code info
- LC+200-D: Lot-N4J030 (Exp.9/20/2026), N5D043(Exp.4/16/2027); LC+225: Lot-N6A025(Exp.1/8/2028)
- Firm FEI number
- 1000142899
- Recalling firm
- Nipro Renal Soultions USA, Corporation
- Address 1
- 509 Fishing Creek Rd
- City
- Lewisberry
- State
- PA
- Postal code
- 17339-9517
- Additional info contact
- Jessica Oswald-McLeod 305-432-6699
- Reason for recall
- Hemodialysis concentrates contain high endotoxin levels
- Root cause description
- Process control
- Product quantity
- 100 drums/1072 cases
- Distribution pattern
- Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama.
- Action
On August 6, 2026 Nipro Medical Corporation issued a Urgent Medical Device Recall notification via Email. Nipro asked consignees to take the following actions: 1. Immediately examine your inventory for the affected product codes and lot numbers listed on the Recall response form. 2. Immediately segregate, quarantine, and discontinue use or distribution of any affected product in your possession. 3. Do not use, sell, transfer, or distribute affected products. 4. Complete the enclosed Recall Response Form within 10 business days, even if you do not have affected product on hand. 5. Contact Nipro customer service for product return and credit, if applicable. 6. If you distributed affected product, promptly notify your customers, provide them with a copy of this recall notice, and request that they complete and return the response form or equivalent confirmation. 7. Product Return or Disposition: Affected products should remain quarantined until return, destruction, or other documented disposition instructions are provided by Nipro. Please retain all documentation related to product quarantine, return, destruction, or other disposition for recall reconciliation.
- K numbers
- K223431
- Harmonized identifiers (openFDA)
- Device name
- Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
- Medical specialty description
- Gastroenterology, Urology
- Regulation number
- 876.5820
- Device class
- 2
- K number
- K864265, K800624, K905021, K253462, K910319, K070177, K971053, K895199, K191093, K072908, K180679, K883068, K820150, K852955, K041428, K012547, K192209, K243786, K131202, K810527, K193155, K030497, K062399, K896111, K940601, K910270, K072760, K982378, K013724, K904946, K811706, K001059, K981043, K851431, K941958, K891921, K993212, K162887, K810280, K990507 +84 more
- Registration number
- 3027241826, 3027592507, 3003464075, 3013546115, 2183415, 3032828299, 3013764800, 2431908, 3035708507, 2029275, 3003591774, 1528807, 3007137482, 8030639, 9611823, 1835498, 1652176, 1225714, 9610725, 3043014136, 1651896, 3019131, 1056186, 3005162618, 3003768032, 9616277, 3010242164, 3012364195, 3038195011, 3004176176, 9610270, 1954315, 3016096143, 3005578748
- FEI number
- 3027241826, 3027592507, 3003310249, 3002807005, 3003464075, 3013546115, 2183415, 3013942511, 3001451489, 3032828299, 3013764800, 2431908, 3035708507, 1000132332, 3003591774, 3007137482, 3003244997, 1527681, 1000306431, 6898, 3043014136, 3002970979, 405, 3010242164, 3003463852, 3012364195, 3004176176, 3038195011, 3001236991, 3006475063, 1000142899, 3012394756, 3016096143, 3005578748
